Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)

Por Felip, Enriqueta, Rosell, Rafael
Publicado em 2008

Targeted Therapies Development in the Treatment of Advanced Nonsmall Cell Lung Cancer

Por Gridelli, Cesare, Felip, Enriqueta
Publicado em 2011

Neoadjuvant chemotherapy in early-stage non-small cell lung cancer

Por Salvà, Francesc, Felip, Enriqueta
Publicado no Transl Lung Cancer Res (2013)

PI3K Pathway in NSCLC

Por Martinez-Martí, Alex, Felip, Enriqueta
Publicado em 2012

Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer

Por Dienstmann, Rodrigo, Martinez, Pablo, Felip, Enriqueta
Publicado em 2011

HER2 driven non-small cell lung cancer (NSCLC): potential therapeutic approaches

Por Garrido-Castro, Ana Christina, Felip, Enriqueta
Publicado no Transl Lung Cancer Res (2013)

Angiogenesis, multitarget kinase inhibitors and non-small cell lung cancer: a lesson from MONET1 trial

Por Mendivil, Alejandro Navarro, Rodriguez, Pablo Martinez, Felip, Enriqueta
Publicado no Transl Lung Cancer Res (2013)

Bone metastases with nerve root compression as a late complication in patient with epithelial pleural mesothelioma

Por Cedrés, Susana, Fariñas, Lorena, Stejpanovic, Neda, Martinez, Pablo, Martinez, Alex, Zamora, Esther, Montero, Maria Angeles, Felip, Enriqueta
Publicado em 2013

Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)

Por Cedrés, Susana, Ponce-Aix, Santiago, Zugazagoitia, Jon, Sansano, Irene, Enguita, Ana, Navarro-Mendivil, Alejandro, Martinez-Marti, Alex, Martinez, Pablo, Felip, Enriqueta
Publicado no PLoS One (2015)

Phase III, randomized, open-label study of durvalumab (MEDI4736) in combination with tremelimumab or durvalumab alone versus platinum-based chemotherapy in first-line treatment of...

Por Rizvi, Naiyer, Barlesi, Fabrice, Brahmer, Julie, Felip, Enriqueta, Forde, Patrick, Garassino, Marina, Goldberg, Sarah, Vansteenkiste, Johan, Jarkowski, Anthony, McIntosh, Stuart, Zhao, Luping, Antonia, Scott
Publicado no J Immunother Cancer (2015)

Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients

Por Martinez, Pablo, Hernández-Losa, Javier, Cedrés, Susana, Castellví, Josep, Martinez-Marti, Alex, Tallada, Natalia, Murtra-Garrell, Nuria, Navarro-Mendivill, Alejandro, Rodriguez-Freixinos, Victor, Canela, Mercedes, Ramon y Cajal, Santiago, Felip, Enriqueta
Publicado em 2013

Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trial

Por Moran, Teresa, Felip, Enriqueta, Keedy, Vicki, Borghaei, Hossein, Shepherd, Frances A, Insa, Amelia, Brown, Holly, Fitzgerald, Timothy, Sathyanarayanan, Sriram, Reilly, John F, Mauro, David, Hsu, Karl, Yan, Li, Johnson, David H
Publicado no Exp Hematol Oncol (2014)

TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial

Por Nemunaitis, John, Papai, Zsolt, Léna, Hervé, Losonczy, Gyorgy, Forget, Frederic, Chouaid, Christos, Szczesna, Alexandra, Gervais, Radj, Ottensmeier, Christian H, Beck, Joseph, Kazarnowicz, Andrzej, Westeel, Virginie, Debieuvre, Didier, Madroszyk, Anne, Felip, Enriqueta, Limacher, Jean Marc, Quoix, Elisabeth
Publicado no J Immunother Cancer (2015)

ERRATUM: Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity

Por Prat, Aleix, Adamo, Barbara, Fan, Cheng, Peg, Vicente, Vidal, Maria, Galván, Patricia, Vivancos, Ana, Nuciforo, Paolo, Palmer, Héctor G., Dawood, Shaheenah, Rodón, Jordi, Cajal, Santiago Ramon y, Campo, Josep Maria Del, Felip, Enriqueta, Tabernero, Josep, Cortés, Javier
Publicado no Sci Rep (2015)

Acquired EGFR C797S mediates resistance to AZD9291 in advanced non-small cell lung cancer harboring EGFR T790M

Por Thress, Kenneth S., Paweletz, Cloud P., Felip, Enriqueta, Cho, Byoung Chul, Stetson, Daniel, Dougherty, Brian, Lai, Zhongwu, Markovets, Aleksandra, Vivancos, Ana, Kuang, Yanan, Ercan, Dalia, Matthews, Sarah, Cantarini, Mireille, Barrett, J. Carl, Jänne, Pasi A., Oxnard, Geoffrey R.
Publicado no Nat Med (2015)

Single-cell transcriptome conservation in cryopreserved cells and tissues

Por Guillaumet-Adkins, Amy, Rodríguez-Esteban, Gustavo, Mereu, Elisabetta, Mendez-Lago, Maria, Jaitin, Diego A., Villanueva, Alberto, Vidal, August, Martinez-Marti, Alex, Felip, Enriqueta, Vivancos, Ana, Keren-Shaul, Hadas, Heath, Simon, Gut, Marta, Amit, Ido, Gut, Ivo, Heyn, Holger
Publicado no Genome Biol (2017)

Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology

Por Gamarra, Fernando, Noël, Julie-Lyn, Brunelli, Alessandro, Dingemans, Anne-Marie C., Felip, Enriqueta, Gaga, Mina, Grigoriu, Bogdan Dragos, Hardavella, Georgia, Huber, Rudolf M., Janes, Samuel, Massard, Gilbert, Putora, Paul Martin, Sculier, Jean-Paul, Schnabel, Philipp A., Ramella, Sara, Van Raemdonck, Dirk, Meert, Anne-Pascale
Publicado no Breathe (Sheff) (2016)

Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer: Results from the Phase II BASALT-1 Study

Por Vansteenkiste, Johan F., Canon, Jean-Luc, De Braud, Filippo, Grossi, Francesco, De Pas, Tommaso, Gray, Jhanelle E., Su, Wu-Chou, Felip, Enriqueta, Yoshioka, Hiroshige, Gridelli, Cesare, Dy, Grace K., Thongprasert, Sumitra, Reck, Martin, Aimone, Paola, Vidam, Gena Atalla, Roussou, Pantelia, Wang, Ying A., Tomaso, Emmanuelle Di, Soria, Jean-Charles
Publicado no J Thorac Oncol (2015)

Intracranial and whole-body response of ceritinib in ALK inhibitor-naïve and previously ALK inhibitor-treated patients with ALK-rearranged non-small-cell lung cancer (NSCLC): updat...

Por Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S W, Felip, Enriqueta, Chow, Laura Q M, Camidge, D Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J, Solomon, Benjamin J, Wolf, Jürgen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Sutradhar, Santosh, Li, Siyu, Szczudlo, Tomasz, Yovine, Alejandro, Shaw, Alice T
Publicado no Lancet Oncol (2016)

BM-32 CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL

Por Shaw, Alice, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Ross Camidge, D., Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Geraldes, Margarida, Sen, Paramita, Boral, Anthony J., Yovine, Alejandro, Kim, Dong-Wan
Publicado em 2014